The main objective of this study is to examine the neural underpinnings of stress reactivity in people with burnout. In turn, we aim to link this stress reactivity to real life stress activity, and in turn to glucocorticoid deficits. We also aim to…
ID
Source
Brief title
Condition
- Somatic symptom and related disorders
- Lifestyle issues
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary study outcome will be the stress reactivity difference in the brain
between people with burnout and controls, and the relationship of this response
to daily life stress reactivity and glucocorticoid dysfunction.
Secondary outcome
The effects of childhood trauma on glucocorticoid dysfunction on burnout will
be examined.
Background summary
Burnout is a condition affecting many people, resulting in loss of
productivity, exhaustion, and depersonalization. A lot of overlap between
burnout and depression exists however, making the understanding of burnout
unclear. One possible distinguishing feature can be dysfunctions in
glucocorticoid systems. Indeed there exists evidence supporting this
conclusion, with a suppressed glucocorticoid system being a prominent feature
of burnout, but not depression. This evidence comes from studies examining the
cortisol awakening response, and using the dexamethasone suppression test.
However, this evidence is not entirely conclusive, as there are also studies
showing the opposite effects. One possible explanation behind these findings
could be the influence of childhood trauma, socioeconomic factors, and possibly
daily life stress reactivity. Furthermore, these glucocorticoid deficits may
have specific neural underpinnings, as reflected by the brains reactivity to
stress. Studies examining the neural circuitry that may be behind burnout are
limited to a handful of studies, and only one study using MRI. None of these
studies however examine the effects of stress on the brain in burnout, which
may be the underlying driving force behind this condition.
Study objective
The main objective of this study is to examine the neural underpinnings of
stress reactivity in people with burnout. In turn, we aim to link this stress
reactivity to real life stress activity, and in turn to glucocorticoid
deficits. We also aim to examine the potential confounding variables that may
also be coming into play such as experiences of trauma.
Study design
This is a case-control study examining difference between people with burnout
and controls. Subjects will perform an intake procedure where they will sign
the consent form. Following consent, subject will complete the Utrecht Burnout
Schaal which measures burnout. Controls who score too high will be excluded at
this point. Subject will then proceed to fill in a survey on trauma experience.
On another day, subjects will return to retrieve watches that collect
physiological data that will be used to measure subjective stress reactivity.
Subjects will use these watches in tandem with surveys that are sent over a
period of 7 days to measure stress reactivity. These surveys are delivered 10
times a day, and require 3 minutes to fill. This method is known as experience
sampling, and is commonly used in many studies with clinical populations. On
three of these days, subjects will also collect saliva samples upon waking, and
at 15 min intervals during the first hour of waking. An additionally four more
samples are collected throughout the day. These allow us to measure potential
glucocorticoid differences in subjects with burnout.
Upon completion of this week, subject return to the study site, where they
engage in tasks that measure effort-reward trade offs, and will also collect a
dexamethasone tablet on this day to use in the evening. Upon returning home
subjects are expected to take the pill orally before bed time, and collect
saliva samples as they did on previous days during the testing week.
Finally, each subject will complete two scans on separate days. The purpose of
the first scan is to acquire structural images, and to get subjects accustomed
to being in a scanner. The second scan day will be a functional MRI scan
examining brain activity under stress. This will be the last testing period of
this study, and after completion subject will be debriefed.
Study burden and risks
This study require a significant time investment. While it is a minimal risk
study, there may be a potential psychological burden associated with filling in
surveys throughout the day, and possible negative emotions elicited from the
questionnaires used. MRI is generally safe when taking into account the strict
exclusion criteria adhered to. Potential discomfort from laying in the scanner
may arise, and from being in confined spaces. This is accounted for by ensuring
subjects are laying comfortably in the scanner, and with the addition of
support cushions where necessary. Subjects are also screened for feelings of
claustrophobia, no rule out discomfort associated with small spaces. Subjects
themselves will not receive direct benefit from participation beyond monitory
compensation. This study will benefit burnout by attempting to further
elaborating on mechanisms behind this condition, and potentially paving the way
to new studies examining targeted treatments that focus of the glucocorticoid
system.
Kapittelweg 29
Nijmegen 6525EN
NL
Kapittelweg 29
Nijmegen 6525EN
NL
Listed location countries
Age
Inclusion criteria
* Age 18-55 years
* Native Dutch speakers
* Right-handed
* Normal or corrected to normal vision
* For females: Free cycling,
- Additionally, patients will need to have received a diagnosis from HSK
clinics characterized as unidentified somatoform disorder, adjustment disorder
(DSM-V) or from AMDumc with a diagnosis of burnout.
Exclusion criteria
*General exclusion criteria for fMRI:
Metal implants or splinters, surgical clips, prostheses, artificial heart
valves, claustrophobia, electronic equipment in body (such as a pacemaker),
preg-nancy, and epilepsy. Furthermore, a potential subject who meets any of the
following criteria will be excluded from participation in this study:,
* Psychiatric:
o Current major depression, or ADHD
o Lifetime history of bipolar disorder, schizophrenia, delusional disorder,
schizoaffective disorder, schizophreniform disorder or other psychotic disorders
o Schizoid or schizotypal personality disorder
o Current alcohol- or substance dependence
o Mental retardation (IQ<70 estimated), * Somatic:
o History of trauma capitis
o Neurological disorders
o Current fungal infections
* Pre-testing use of drugs and substances:
o Use of alcohol more than 3 units/day during the week before experimental
measures
o Use of alcohol within 24 hours before measurement.
o Use of recreational drugs within the week before measurement.
o Use of any psychotropic medication, other than oxazepam, or comparable mi-nor
tranquilizer/sleep medication, during the 5 days before measurement.
o Use of oxazepam, or comparable minor tranquilizer/sleep medication, within 12
hours before measurement.
o Smoking within 3 hours before measurement.,
* For females: Pregnancy and/or use of oral contraceptive,
* For controls: A score of 3 or greater on the Burnout Assessment Inventory.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL69785.091.19 |